13F HOLDINGS REPORT
Frazier Life Sciences Management, L.P.
Quarter ended Q1 2023 · Filed February 3, 2023 · Accession 0001420506-23-000230
Total Value
$1.6M
Positions
44
Other Managers
0
Confidential Omitted
No
Holdings (44)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HILLEVAX INC | 43157M102 | 9,758,359 | $163,257 | 10.15% |
| 2 | IMAGO BIOSCIENCES INC | 45250K107 | 3,987,207 | $143,340 | 8.91% |
| 3 | Arcutis Biotherapeutics | ARQT | 8,684,232 | $128,527 | 7.99% |
| 4 | CHINOOK THERAPEUTICS INC | 16961L106 | 4,345,559 | $113,854 | 7.08% |
| 5 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 9,341,551 | $101,823 | 6.33% |
| 6 | Syndax Pharmaceuticals, Inc. | SNDX | 3,708,838 | $94,390 | 5.87% |
| 7 | Phathom Pharmaceuticals, Inc. | PHAT | 8,407,152 | $94,328 | 5.86% |
| 8 | KRYSTAL BIOTECH INC | KRYS | 999,737 | $79,199 | 4.92% |
| 9 | Mirum Pharmaceuticals, Inc. | MIRM | 3,860,107 | $75,272 | 4.68% |
| 10 | VERONA PHARMA PLC | 925050106 | 2,815,720 | $73,575 | 4.57% |
| 11 | Vaxcyte, Inc. | PCVX | 1,397,405 | $67,006 | 4.17% |
| 12 | RHYTHM PHARMACEUTICALS INC | RYTM | 1,894,000 | $55,153 | 3.43% |
| 13 | ALLAKOS INC | 01671P100 | 4,792,000 | $40,349 | 2.51% |
| 14 | ANAPTYSBIO INC | ANABV | 899,700 | $27,882 | 1.73% |
| 15 | Tarsus Pharmaceuticals, Inc. | TARS | 1,787,527 | $26,205 | 1.63% |
| 16 | CRINETICS PHARMACEUTICALS IN | CRNX | 1,414,823 | $25,891 | 1.61% |
| 17 | REPLIMUNE GROUP INC | REPL | 931,560 | $25,338 | 1.58% |
| 18 | COGENT BIOSCIENCES INC | COGT | 2,109,154 | $24,382 | 1.52% |
| 19 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,985,757 | $21,945 | 1.36% |
| 20 | KALVISTA PHARMACEUTICALS INC | KALV | 3,238,859 | $21,895 | 1.36% |
| 21 | GRITSTONE BIO INC | 39868T105 | 5,162,348 | $17,810 | 1.11% |
| 22 | SUTRO BIOPHARMA INC | STRO | 1,776,479 | $14,354 | 0.89% |
| 23 | ACADIA PHARMACEUTICALS INC | ACAD | 857,338 | $13,649 | 0.85% |
| 24 | SILENCE THERAPEUTICS PLC | SLNCF | 881,173 | $13,438 | 0.84% |
| 25 | TREVI THERAPEUTICS INC | TRVI | 6,663,590 | $12,861 | 0.80% |
| 26 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 393,000 | $12,395 | 0.77% |
| 27 | MERUS N V | N5749R100 | 746,479 | $11,548 | 0.72% |
| 28 | VECTIVBIO HLDG AG | H9060V101 | 1,333,400 | $11,481 | 0.71% |
| 29 | AVIDITY BIOSCIENCES INC | 05370A108 | 500,000 | $11,095 | 0.69% |
| 30 | Immunovant, Inc. | IMVT | 585,759 | $10,397 | 0.65% |
| 31 | TYRA BIOSCIENCES INC | TYRA | 1,327,665 | $10,090 | 0.63% |
| 32 | BLUEBIRD BIO INC | 09609G100 | 1,440,757 | $9,970 | 0.62% |
| 33 | ARVINAS INC | ARVN | 285,331 | $9,761 | 0.61% |
| 34 | PROTHENA CORP PLC | PRTA | 127,900 | $7,706 | 0.48% |
| 35 | AUTOLUS THERAPEUTICS PLC | AUTL | 3,746,857 | $7,119 | 0.44% |
| 36 | INTELLIA THERAPEUTICS INC | NTLA | 203,684 | $7,107 | 0.44% |
| 37 | THESEUS PHARMACEUTICALS INC | 88369M101 | 1,398,194 | $6,963 | 0.43% |
| 38 | Passage Bio, Inc. | PASG | 3,756,915 | $5,185 | 0.32% |
| 39 | ZYMEWORKS DEL INC | ZYME | 610,000 | $4,795 | 0.30% |
| 40 | ACLARIS THERAPEUTICS INC | ACRS | 290,189 | $4,570 | 0.28% |
| 41 | ESSA Pharma, Inc. | 29668H708 | 605,141 | $1,525 | 0.09% |
| 42 | APTINYX INC | 03836N103 | 1,883,244 | $537 | 0.03% |
| 43 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 500,333 | $434 | 0.03% |
| 44 | NABRIVA THERAPEUTICS PLC | G63637139 | 17,025 | $32 | 0.00% |